Lindbrook Capital’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,077
Closed -$68.1K 2969
2022
Q4
$68.1K Sell
4,077
-268
-6% -$4.53K 0.01% 586
2022
Q3
$75K Buy
4,345
+44
+1% +$691 0.01% 526
2022
Q2
$34K Buy
4,301
+231
+6% +$1.99K 0.01% 798
2022
Q1
$45K Buy
4,070
+50
+1% +$560 0.01% 714
2021
Q4
$71K Buy
4,020
+20
+0.5% +$388 0.01% 606
2021
Q3
$81K Hold
4,000
0.02% 316
2021
Q2
$132K Hold
4,000
0.03% 239
2021
Q1
$156K Hold
4,000
0.04% 192
2020
Q4
$175K Hold
4,000
0.04% 159
2020
Q3
$113K Hold
4,000
0.03% 188
2020
Q2
$145K Hold
4,000
0.04% 155
2020
Q1
$73K Buy
+4,000
New +$87.7K 0.03% 233

Lindbrook Capital's ONEM Position: Q1 2023 in Review

Lindbrook Capital sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 4,077 shares — an estimated $68.1K sold.

Lindbrook Capital first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $175K in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Lindbrook Capital reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Lindbrook Capital sold 4,077 1Life Healthcare shares in Q1 2023, an estimated $68.1K.
  • Lindbrook Capital first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • Lindbrook Capital's 1Life Healthcare position peaked at $175K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.